Business Wire | Nov 22, 2021 08:01AM EST

Paragon 28 to Present at Piper Sandler 33rd Annual Healthcare Conference

Nov. 22, 2021

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Nov. 22, 2021--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will virtually present at the Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will also be hosting virtual investor meetings on November 30and December 1.

The pre-recorded fire-side chat will be available for on-demand viewing beginning Wednesday, November 24, 2021, at 8:00am MT / 10:00am ET. The webcast, as well as the archived recording, will be available on the investor relations section of the Company's website at ir.paragon28.com.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28(r) has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122006030/en/

CONTACT: Investor Contact: Gilmartin Group Matt Bacso, CFA investors@neuropace.com